FREDERICK, Md., Jan. 9, 2014 /PRNewswire/ -- BioElectronics
Corporation (OTC Pink: BIEL), the maker of advanced consumer
medical devices, announced today the publication of feature article
The Case for Over-the-Counter Shortwave Therapy: Safe and
Effective Devices for Pain Management in the peer reviewed
journal Pain Management
(http://www.futuremedicine.com/doi/full/10.2217/pmt.13.60). The
current methods of drug-based analgesia are often ineffective, at
best only temporarily masking pain while not treating or providing
the benefit of enhanced recovery.
(Photo: http://photos.prnewswire.com/prnh/20140109/PH43397)
The paper makes the case for more widespread use of radio
frequency shortwave devices to overcome the dosage limitations,
costs, and side-effects of pharmacological-based pain relief. To
view the complete article, please visit
http://www.futuremedicine.com/doi/full/10.2217/pmt.13.60
There is a dire unmet medical need for effective and safe pain
therapy. For decades, physicians have used pulsed shortwave therapy
in hospitals and clinics to reduce pain and inflammation and
accelerate healing. BioElectronics has taken the therapy mode,
miniaturized the device, lowered the power level and honed the
signal to provide low cost superior 24-hour extended duration
relief. The devices provides 5x better pain relief than OTC drugs,
are 100% safer, and provide 720-hours of flexible on/off therapy
for under $30.00 retail, or
$.04 per hour.
Clinical Research
In addition to its six (6) published
studies, there is on-going basic research at the Clinical Science
and Engineering Research Center – State
University of New York, Binghamton, NY and other leading
medical institutions that are conducing additional clinical
research studies:
|
Tufts Dental School,
Boston, Massachusetts
|
3rd. Molar
Extraction, Pain and Edema
|
|
Tufts Dental
School
|
Myofascial
Pain
|
|
Tufts Medical
School
|
Chronic
Wounds
|
|
University of British
Colombia, Vancouver, Canada
|
Plantar Fasciitis
recovery at 26 weeks
|
|
University of Otago,
New Zealand
|
Lower Back
Pain
|
|
University Hospital
Ghent, Belgium
|
Bilateral Hernia
Surgical Recovery
|
|
University Hospital
G. Martin, Messina, Italy
|
Osteoarthritis
|
|
Aarhus University
Hospital, Aalborg, Denmark
|
Venous Ulcer Wound
Healing
|
The details on previously completed and published clinical
trials can be found at
http://www.bielcorp.com/clinical-evidence/.
About BioElectronics Corporation
BioElectronics is
the leader in consumer medical devices that reduce pain,
inflammation and accelerate healing. Its products are
ActiPatch® Musculoskeletal Pain Therapy for back, knee, and other
musculoskeletal complaints; RecoveryRx® for chronic and
post-operative wound care; HealFast® Veterinary Therapy, Allay®
Menstrual Pain Therapy and Smart Insole™ Heel Pain Therapy.
Visit www.bielcorp.com for more information.
About the Pain Management Journal
Future Medicine Ltd,
the publisher, has developed an innovative publishing portfolio to
reflect the advances in postgenomic medicine and to guide best
clinical practice in modern medicine. The Future Medicine
journal collection provides healthcare practitioners and research
professionals with a unique source of objective, cutting-edge
information on exciting trends emerging in the light of advances in
molecular medicine and clinical practice.
BioElectronics Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation